Company Search:
Advanced Search
Sponsored Links
Ortivus AB Company Snapshot
Ortivus AB operates in the Electromedical equipment sector. In addition to historical fundamental analyses, the complete report available to purchase compares Ortivus AB with three other companies in this sector in Sweden: Glycorex Transplantation AB (publ) (2017 sales of 29.56 million Swedish Kronor [US$3.25 million] ), Arcoma AB (91.85 million Swedish Kronor [US$10.10 million] ), and Scandidos AB (47.41 million Swedish Kronor [US$5.22 million] ).

Sales Analysis. Ortivus AB reported sales of SEK 58.80 million (US$6.47 million) for the year ending December of 2017. This represents a decrease of 20.8% versus 2016, when the company's sales were SEK 74.28 million. The sales level in 2017 was fairly close to the level five years ago: in 2012, Ortivus AB had sales of SEK 60.71 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Ortivus AB
  Stock Performance Chart for Ortivus AB
  Stock Data: Recent Stock Performance:
  Current Price (12/7/2018): 1.54
(Figures in Swedish Kronor)
1 Week -14.4%   13 Weeks -13.4%  
4 Weeks -16.8%   52 Weeks -28.4%  
Ortivus AB Key Data:
  Ticker: ORTI B Country: Sweden
  Exchanges: STO Major Industry: Health Care Equipment & Services
    Sub Industry: Electromedical Equipment
  2017 Sales 58,799,000
(Year Ending Jan 2018).
Employees: 21
  Currency: Swedish Kronor Market Cap: 47,962,963
  Fiscal Yr Ends: December Shares Outstanding: 31,144,781
  Share Type: B Fri Aktie Closely Held Shares: 7,699,576
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.